MedPath

HES and Acute Kidney Injury in Adult Cardiac Surgery

Completed
Conditions
Acute Kidney Injury After Adult Cardiac Surgery
Interventions
Drug: Crystalloid
Registration Number
NCT02445820
Lead Sponsor
University of Liege
Brief Summary

This study retrospectively assess the effect or using balanced hydroxyethyl sctarch (HES) 130/0.4 or a balanced crystalloid solution as a pump prime and for intraoperative fluid therapy on the risk of early acute postoperative kidney injury in adult cardiac surgery patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
697
Inclusion Criteria
  • Age ≥ 18 yo
  • Having on pump cardiac surgery at CHU of Liège between April 2013 and June 2014
Exclusion Criteria
  • Off pump surgery
  • Use of Blood or Albumin in the cardiopulmonary bypass priming solution
  • Preoperative dialysis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CrystalloidCrystalloidBalanced Crystalloid used as a pump prime and for intraoperative fluid therapy.
HESHESBalanced HES 130/0.4 used as and pump prime and for intraoperative fluid therapy.
Primary Outcome Measures
NameTimeMethod
AKIN SCrForty eight hours

Stage of acute kidney injury using the Acute Kidney Injury Network Classification omitting the diuresis criteria.

Secondary Outcome Measures
NameTimeMethod
ICU stay30 days

Length of stay at the intensive care unit

Hospital stay30 days

Length of stay at the hospital

30-day mortality30 days

Death in hospital or within 30 days of surgery

AKIN SCr+UOForty eight hours

Stage of acute kidney injury using the Acute Kidney Injury Network Classification including the diuresis criteria.

Postoperative dialysis30 days

Requirement of postoperative renal replacement therapy

Respiratory complication30 days

Need for reintubation, non-invasive ventilation or prolonged intensive care unit stay as a consequence of atelectasis, pulmonary edema or pneumonia.

© Copyright 2025. All Rights Reserved by MedPath